Video Blog Video blogger Mark S. King was in Vienna to cover AIDS 2010 from his fabulous point of view. July 23: AIDS 2010: A Final Look July 22: AIDS 2010 Day Four: The Art of AIDS More Videos ... Day 0: MSM Event Day 1: Sex & Lennox Day 2: Youth Wisdom Day 3: Human Rights Day 4: Art of AIDS Day 5: A Final Look

Study Finds Microbicide Containing HIV Drug Lowers Infection Risk in Women By 39% For the first time, a microbicide gel containing an HIV medication has been found to have some protective effect against HIV -- and even more protective effect against genital herpes. Although the findings are only preliminary and the gel faces years of additional study, the gel's success still represents a huge step in the development of an HIV prevention method that puts the receptive partner in control during sex. More Top Stories: AIDS 2010 Roundup: Men Who Have Sex With Men (MSM) Get Prepared for PrEP: "Treatment as Prevention" Moves Ahead AIDS 2010 Conference Buzz: Closing Reflections More Stories From AIDS 2010

Mark S. King: A Final Look at AIDS 2010 in Vienna "Life is such an arbitrary thing; I was born here, you were born there, she was born over there. That simple geography equation will mean virtually everything when it comes to our human rights, our access to basic health care and services, and how long we will likely live on this planet." More Highlights: Oh Vienna: A River Runs Through the XVIII International AIDS Conference Confessions of a Conference Newbie Conference Buzz: People Reflect on the Atmosphere at AIDS 2010 The Global Village: Vibrant, but Still Not Perfect More		An Anti-Inflammatory Antiretroviral? Meet the CCR5/CCR2 Antagonist TBR-652 What sets TBR-652 apart from other CCR5 antagonists -- heck, all other antiretrovirals on the market today -- is that it's also designed specifically to block another receptor, CCR2, which has been tied to inflammation. More Highlights: Studies Highlight Vitamin D Deficiency Prevalence and Possible Risk Factors in People With HIV TMC278 (Rilpivirine) Stands Up to Efavirenz in Battle of First-Line NNRTIs; FDA Approval May Be Drawing Near Study Examines HIV-Positive Patients' Death Risk at CD4 Counts Above 350 Special Protein Contributes to Control of HIV Infection in Elite Controllers More
Study Finds Microbicide Containing HIV Drug Lowers Infection Risk in Women by 39% Although the findings are only preliminary and the gel faces years of additional study, the gel's success still represents a huge step in the development of an HIV prevention method that puts the receptive partner in control during sex. More Highlights: Q & A With the Researchers Behind the Breakthrough Microbicide New York Times Examines Questions Left Unanswered by Microbicide Trial HIV/AIDS Vaccine Experts Discuss Hopes and Fears for the Future of Vaccine Development Get Prepared for PrEP: "Treatment as Prevention" Moves Ahead More		How Much Slack Should Activists Give Obama? Gary Bell on Bill Clinton's Speech at AIDS 2010 "My respect for Bill Clinton had dwindled as a result of his tactics in campaigning for his wife Hillary against [Barack] Obama. Therefore, I was even more pleased to hear his common-sense defense of President Obama." More Highlights: From Policy to Pregnancy: Sexual Rights and Reproductive Options for People Living With HIV/AIDS Where HIV Care Is Rare and Precious, 4,000 May Be About to Lose It Human Rights Now! A Video Blog Entry by Mark S. King At Closing Ceremony, a Sharp Look at U.S. Domestic Policies on HIV/AIDS More

The International AIDS Conference is easily the largest formal gathering of HIV/AIDS community members on the planet. Originally meant to provide researchers with a global forum for discussing the latest developments in the field, in recent years the conference has increasingly become more of a political, social and community event. It now involves nearly 20,000 attendees and features a vast array of events, presentations, protests, speeches and discussions that explore every corner of the HIV/AIDS pandemic.

The conference takes place once every two years; this year brings us the XVIII International AIDS Conference in Vienna, Austria. The last conference was held in Mexico City in 2008 and was attended by 30,000 people.

For more information on AIDS 2010, we recommend you visit the official conference Web site, where you may also view the conference program.